Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sunder Biomedical Tech. Co., Ltd. (4115:TWSE), powered by AI.
Sunder Biomedical Tech. Co., Ltd. is currently trading at $7.76. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sunder Biomedical Tech. Co., Ltd. on Alpha Lenz.
View Sunder Biomedical Tech. Co., Ltd.'s valuation metrics on Alpha Lenz.
“Sunder Biomedical Tech. Co., Ltd.'s ROE is -2.1%. Explore profitability and growth together.”
Ask for details →Sunder Biomedical Tech. Co., Ltd. is a manufacturer specializing in medical consumables and equipment, established in 1998 and headquartered in Taichung, Taiwan. The company focuses on the design, production, and distribution of a wide array of medical devices and disposable products critical to healthcare delivery. Its product portfolio includes protective goggles, meltblown nonwoven fabrics and masks, suction irrigation sets, smoke filters, endoscopic retrieval bags, blood line sets for hemodialysis, A.V. fistula needle sets, and various types of infusion and extension tubing. Additionally, Sunder Biomedical supplies medical-grade PVC compounds, components, and transducer protectors, highlighting its role as a supplier of both finished products and raw materials for the healthcare industry. The company also provides sterilization and laboratory services, catering to hospitals, clinics, and laboratories. By serving the global health technology and medical specialties market, Sunder Biomedical Tech. Co., Ltd. supports the safety and efficiency of clinical procedures and the supply chain for medical disposables, underpinning its significance in the healthcare sector with a focus on regulatory compliance, manufacturing quality, and technological innovation.
“Sunder Biomedical Tech. Co., Ltd.'s ROE is -2.1%. Explore profitability and growth together.”
Ask for details →Sunder Biomedical Tech. Co., Ltd. (ticker: 4115) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).
The current price is 7.76 with a P/E ratio of -x and P/B of -x.
ROE is -2.12% and operating margin is -2.30%. Annual revenue is $753M.